Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
Brain, Blood And Clot or Tissue Registry And Collaboration
for
Acute Ischemic Stroke, Cerebrovascular Disorders
Location: Lexington KY
Sponsor: Justin Fraser
Sex: All
Age: 18+
Code: NCT03153683
Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
for
Traumatic Brain Injury
Location: Baltimore MD, Durham NC, West Palm Beach FL, Detroit MI,
Sponsor: Gaylan Rockswold
Sex: All
Age: 16 - 65
Code: NCT02407028
Phase 2, Recruiting
EffectiveNess and SAfety of Small ANeurysm COiling Trial
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
for
Atrial Fibrillation, Postoperative
Location: Louisville KY
Sponsor: Helios Cardio Inc.
Sex: All
Age: 20 - 70+
Code: NCT06730828
Phase 1, Phase 2, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Boston MA, Richmond VA, Durham NC, Pittsburgh PA,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase 3, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Stony Brook NY, Bay Shore NY, Lake Success NY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase 3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
Prospective Analysis of Spinal Epidural Abscess
for
Spinal Epidural Abscess
Location: Lexington KY
Sponsor: Francis Farhadi
Sex: All
Age: 18+
Code: NCT05464251
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase 3, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase 3, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma